Genelux Corporation
GNLX • NASDAQ
Genelux Corporation is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Thomas D. Zindrick, with a market cap of $111.1M.
Market Cap$111.1M
Employees23.0
CEOThomas D. Zindrick
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 5, 2026 · In 3 weeksQ1 2026
Financials
Genelux Corporation FAQ
Common questions about Genelux Corporation
Genelux Corporation is scheduled to report earnings for Q1 2026 on May 5, 2026.
Genelux Corporation has approximately 23 employees.